Number of the records: 1  

POLYPEPTIDE ANTAGONISTS OF HUMAN IL-23 RECEPTOR FOR TREATMENT OF AUTOIMMUNE DISEASES

  1. 1.
    SYSNO ASEP0470240
    Document TypeP - Patent
    R&D Document TypePatent or other outcome protected by special legislation
    TitlePOLYPEPTIDE ANTAGONISTS OF HUMAN IL-23 RECEPTOR FOR TREATMENT OF AUTOIMMUNE DISEASES
    Author(s) Malý, Petr (BTO-N) RID, ORCID
    Šebo, Peter (BTO-N)
    Kuchař, Milan (BTO-N) RID
    Vaňková, Lucie (BTO-N)
    Petroková, Hana (BTO-N) RID
    Osička, Radim (MBU-M) RID, ORCID
    Year of issue2017
    Possible third party use of the resultA - Pro využití výsledku jiným subjektem je vždy nutné nabytí licence
    Royalty requestedA - Poskytovatel licence požaduje licenční poplatek
    Patent no. or utility model no. or industrial design no.EP2922560
    Date of the patent acceptance04.01.2017
    Name of the patent ownerBiotechnologický ústav AV ČR, v. v. i.
    Code of the issuer nameEPO_1 - European Patent Office Munich, The Hague, Berlin, Vienna, Brusselshttp://www.epo.org/
    Current useA - Pouze udělený (dosud nevyužívaný) patent nebo patent využívaný jeho vlastníkem
    Languageeng - English
    Keywordspsoriasis ; IL - 23 ; binding protein
    Subject RIVEB - Genetics ; Molecular Biology
    Subject RIV - cooperationInstitute of Microbiology - Microbiology, Virology
    Institutional supportBTO-N - RVO:86652036 ; MBU-M - RVO:61388971
    AnnotationThe present invention provides a novel class of polypeptides (REX binders), derived from an albumin-binding domain of the streptococcal protein G that inhibit binding of human IL-23 cytokine to its cognate IL-23 receptor. Blocking of interaction between p19/IL-23 subunit with the receptor leads to the suppresion of IL-23-dependent pro-inflammatory signaling pathway, resulting in an inhibitory effect on IL-23-stimulated Th-17 cell expansion. The invention further provides a DNA sequence encoding for such polypeptides and host cells containing such sequence. The polypeptides of the invention are useful as therapeutics and diagnostics.˙
    WorkplaceInstitute of Biotechnology
    ContactMonika Kopřivová, Monika.Koprivova@ibt.cas.cz, Tel.: 325 873 700
    Year of Publishing2017
    Electronic addresshttps://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=cz_CZ&FT=D&date=20150930&CC=EP&NR=2922560A1&KC=A1#
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.